Phase I study of cetuximab, intensity-modulated radiotherapy (C-IMRT), and intratumoral EGFR antisense (AS) DNA in patients with locally advanced head and neck cancer (HNC). This is an ASCO Meeting ...
June 3, 2008 (Chicago, Illinois) — Acupuncture could be a viable option for reducing pain and dysfunction after neck dissection in head and neck cancer patients, new data suggest. The results of a ...
National Comprehensive Cancer Network Infusion Efficiency Workgroup Study: Optimizing Patient Flow in Infusion Centers This guideline aims to clarify the fundamental principles of neck management in ...